APA

Manner H., Jung B., Tonassi L., Hackenberg U., Plum N., Josten K. M., Kirchmaier C. M. & Frickhofen N. (20080624). Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. : The American journal of the medical sciences.

Chicago

Manner Hendrik, Jung Bernd, Tonassi Leonhard, Hackenberg Ulrich, Plum Nicola, Josten Klaus M, Kirchmaier Carl M and Frickhofen Norbert. 20080624. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. : The American journal of the medical sciences.

Harvard

Manner H., Jung B., Tonassi L., Hackenberg U., Plum N., Josten K. M., Kirchmaier C. M. and Frickhofen N. (20080624). Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. : The American journal of the medical sciences.

MLA

Manner Hendrik, Jung Bernd, Tonassi Leonhard, Hackenberg Ulrich, Plum Nicola, Josten Klaus M, Kirchmaier Carl M and Frickhofen Norbert. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. : The American journal of the medical sciences. 20080624.